[Federal Register Volume 86, Number 101 (Thursday, May 27, 2021)]
[Notices]
[Page 28540]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-11170]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-41-2021]


Foreign-Trade Zone (FTZ) 7--Mayaguez, Puerto Rico; Notification 
of Proposed Production Activity; AbbVie Ltd. (Pharmaceutical Products), 
Barceloneta, Puerto Rico

    AbbVie Ltd. (AbbVie), submitted a notification of proposed 
production activity to the FTZ Board for its facility in Barceloneta, 
Puerto Rico. The notification conforming to the requirements of the 
regulations of the FTZ Board (15 CFR 400.22) was received on May 19, 
2021.
    AbbVie already has authority to produce pharmaceutical products 
within Subzone 7I. The current request would add a finished product and 
a foreign status material to the scope of authority. Pursuant to 15 CFR 
400.14(b), additional FTZ authority would be limited to the specific 
foreign-status material and specific finished product described in the 
submitted notification (as described below) and subsequently authorized 
by the FTZ Board.
    Production under FTZ procedures could exempt AbbVie from customs 
duty payments on the foreign-status materials/components used in export 
production. On its domestic sales, for the foreign-status materials/
components noted below and in the existing scope of authority, AbbVie 
would be able to choose the duty rates during customs entry procedures 
that applies to IMBRUVICA[supreg] capsules and tablets (duty-free). 
AbbVie would be able to avoid duty on foreign-status components which 
become scrap/waste. Customs duties also could possibly be deferred or 
reduced on foreign-status production equipment.
    The material sourced from abroad is Ibrutinib active pharmaceutical 
ingredient (duty rate 6.5%). The request indicates that Ibrutinib is 
subject to duties under Section 301 of the Trade Act of 1974 (Section 
301), depending on the country of origin. The applicable Section 301 
decisions require subject merchandise to be admitted to FTZs in 
privileged foreign status (19 CFR 146.41).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary and sent to: 
[email protected]. The closing period for their receipt is July 6, 2021.
    A copy of the notification will be available for public inspection 
in the ``Reading Room'' section of the Board's website, which is 
accessible via www.trade.gov/ftz.
    For further information, contact Christopher Wedderburn at 
[email protected].

    Dated: May 21, 2021.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2021-11170 Filed 5-26-21; 8:45 am]
BILLING CODE 3510-DS-P